肺炎検査市場：タイプ、方法、技術、エンドユーザー別-2023-2030年の世界予測

肺炎検査市場は、2022年の14億1,000万米ドルから2030年には22億8,000万米ドルに達すると予測され、予測期間中のCAGRは6.17%です。

肺炎検査の世界市場

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは肺炎検査市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度：新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています：

1.肺炎検査市場の市場規模および予測は？

2.肺炎検査市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は？

3.肺炎検査市場における競争戦略の窓とは？

4.肺炎検査市場の最新技術動向と規制の枠組みは？

5.肺炎検査市場における主要ベンダーの市場シェアは？

6.肺炎検査市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界の高齢者人口の増加に伴い肺炎の有病率が増加
    • 肺炎に対する意識を高めるためのヘルスケア機関による取り組みの利用可能性
    • 肺炎に対するポイントオブケア検査（POCT）への関心の高まり
  • 抑制要因
    • 包括的な肺炎検査のコストが高い
  • 機会
    • 肺炎に対する高度で迅速かつ正確な診断検査の開発の増加
    • 革新的なバイオマーカーベースの検査の可能性を拡大
  • 課題
    • リソースが制限された設定でのテストへのアクセスが制限されている
• 市場セグメンテーション分析
• 市場動向分析
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み

第6章 肺炎検査市場：タイプ別

• 機器
• 試薬と消耗品

第7章 肺炎検査市場：方法別

• 免疫診断
• 分子診断学
• ポイントオブケア検査

第8章 肺炎検査市場：技術別

• 酵素免疫測定法
• 免疫蛍光
• 免疫組織化学
• ポリメラーゼ連鎖反応
• ウエスタンブロット

第9章 肺炎検査市場：エンドユーザー別

• 診断研究所
• 病院とクリニック

第10章 南北アメリカの肺炎検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の肺炎検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの肺炎検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

• 主要な企業プロファイル
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Curetis GmbH
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Hain Lifescience GmbH by Bruker Corporation
  • Hologic, Inc.
  • Intec Products, Inc.
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • OpGen Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
  • True Bearing Diagnostics, Inc.
• 主要な製品ポートフォリオ

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. PNEUMONIA TESTING MARKET RESEARCH PROCESS
• FIGURE 2. PNEUMONIA TESTING MARKET SIZE, 2022 VS 2030
• FIGURE 3. PNEUMONIA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. PNEUMONIA TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 5. PNEUMONIA TESTING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 6. PNEUMONIA TESTING MARKET DYNAMICS
• FIGURE 7. PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 8. PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2022 VS 2030 (%)
• FIGURE 10. PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
• FIGURE 12. PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 14. PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 16. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
• FIGURE 18. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 23. PNEUMONIA TESTING MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 24. PNEUMONIA TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. PNEUMONIA TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. PNEUMONIA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 6. PNEUMONIA TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. PNEUMONIA TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 9. PNEUMONIA TESTING MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. PNEUMONIA TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. PNEUMONIA TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 13. PNEUMONIA TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. PNEUMONIA TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. PNEUMONIA TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. PNEUMONIA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. PNEUMONIA TESTING MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. PNEUMONIA TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. PNEUMONIA TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. CANADA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CANADA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 36. CANADA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 37. CANADA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. CHINA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. CHINA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 58. CHINA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. CHINA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. INDIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. INDIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 62. INDIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. INDIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. ITALY PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. ITALY PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 131. ITALY PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. ITALY PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. POLAND PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. POLAND PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 147. POLAND PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. POLAND PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. QATAR PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. QATAR PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 151. QATAR PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. QATAR PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. PNEUMONIA TESTING MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 190. PNEUMONIA TESTING MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 191. PNEUMONIA TESTING MARKET LICENSE & PRICING

The Pneumonia Testing Market is projected to reach USD 2.28 billion by 2030 from USD 1.41 billion in 2022, at a CAGR of 6.17% during the forecast period.

Global Pneumonia Testing Market

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Pneumonia Testing Market.

Based on Type, market is studied across Instruments and Reagents & Consumables. The Instruments is projected to witness significant market share during forecast period.

Based on Method, market is studied across Immunodiagnostics, Molecular Diagnostics, and Point of Care Testing. The Point of Care Testing is projected to witness significant market share during forecast period.

Based on Technology, market is studied across Enzyme Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry, Polymerase Chain Reaction, and Western Blot. The Immunohistochemistry is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Diagnostic Laboratories and Hospitals & Clinics. The Diagnostic Laboratories is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Pneumonia Testing Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Pneumonia Testing Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Pneumonia Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Curetis GmbH, Danaher Corporation, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Hain Lifescience GmbH by Bruker Corporation, Hologic, Inc., Intec Products, Inc., Luminex Corporation, Meridian Bioscience, Inc., OpGen Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Quidel Corporation, Sekisui Diagnostics, LLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and True Bearing Diagnostics, Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Pneumonia Testing Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Pneumonia Testing Market?

3. What is the competitive strategic window for identifying opportunities in the Pneumonia Testing Market?

4. What are the latest technology trends and regulatory frameworks in the Pneumonia Testing Market?

5. What is the market share of the leading vendors in the Pneumonia Testing Market?

6. Which modes and strategic moves are suitable for entering the Pneumonia Testing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Pneumonia Testing Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of pneumonia with expanding geriatric population worldwide
    • 5.1.1.2. Availability of initiatives by healthcare organizations to raise awareness about pneumonia
    • 5.1.1.3. Growing inclination towards point-of-care testing (POCT) for pneumonia
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of comprehensive pneumonia testing
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing development of advanced rapid and accurate diagnostic tests for pneumonia
    • 5.1.3.2. Expanding potential for innovative biomarker-based tests
  • 5.1.4. Challenges
    • 5.1.4.1. Limited access to testing in resource-limited settings
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Pneumonia Testing Market, by Type

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Reagents & Consumables

7. Pneumonia Testing Market, by Method

• 7.1. Introduction
• 7.2. Immunodiagnostics
• 7.3. Molecular Diagnostics
• 7.4. Point of Care Testing

8. Pneumonia Testing Market, by Technology

• 8.1. Introduction
• 8.2. Enzyme Linked Immunosorbent Assay
• 8.3. Immunofluorescence
• 8.4. Immunohistochemistry
• 8.5. Polymerase Chain Reaction
• 8.6. Western Blot

9. Pneumonia Testing Market, by End-user

• 9.1. Introduction
• 9.2. Diagnostic Laboratories
• 9.3. Hospitals & Clinics

10. Americas Pneumonia Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Pneumonia Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Pneumonia Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

• 14.1. Key Company Profiles
  • 14.1.1. Abbott Laboratories
  • 14.1.2. Becton, Dickinson and Company
  • 14.1.3. Bio-Rad Laboratories, Inc.
  • 14.1.4. bioMerieux SA
  • 14.1.5. Curetis GmbH
  • 14.1.6. Danaher Corporation
  • 14.1.7. DiaSorin S.p.A.
  • 14.1.8. Eurofins Scientific SE
  • 14.1.9. F. Hoffmann-La Roche Ltd
  • 14.1.10. Hain Lifescience GmbH by Bruker Corporation
  • 14.1.11. Hologic, Inc.
  • 14.1.12. Intec Products, Inc.
  • 14.1.13. Luminex Corporation
  • 14.1.14. Meridian Bioscience, Inc.
  • 14.1.15. OpGen Inc.
  • 14.1.16. QIAGEN N.V.
  • 14.1.17. Quest Diagnostics Incorporated
  • 14.1.18. Quidel Corporation
  • 14.1.19. Sekisui Diagnostics, LLC
  • 14.1.20. Siemens Healthineers AG
  • 14.1.21. Thermo Fisher Scientific Inc.
  • 14.1.22. Trinity Biotech PLC
  • 14.1.23. True Bearing Diagnostics, Inc.
• 14.2. Key Product Portfolio

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing